Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/2010
01/05/2010US7642057 Using peptide nucleic acid probes to detect chromosome aberrations in eukaryotic cells
01/05/2010US7642054 "STRAP" and "STEAP" (six transmembrane epithelial antigen of the prostate)
01/05/2010US7642046 Inducing signalosome formation in cells, lysing and incubating the cell lysate on a solid phase coated with antibody capable of capturing the receptor within the signalosome, separating solid phase from the cell lysate, and detecting and measuring the amount of the protein bound to the solid phase
01/05/2010US7642044 Trimerising module
01/05/2010US7641910 Amino acid sequence or immunogenic fragment of at least 15 contiguous amino acid sequence when administered to a subject induce antibody or T-cell mediated immune response that recognizes polypeptide
01/05/2010US7641909 Nonstructural and nonstructural proteins from attenuated dengue-2 virus, and structural protein from West Nile virus; vaccines
01/05/2010US7641905 Methods of inducing an immune response
01/05/2010US7641899 Methods for inhibiting IL-TIF-induced proliferation of hematopoietic cells using the cytokine receptor Zcytor16
01/05/2010US7641897 Feeder layer and serum independent embryonic stem cells
01/05/2010CA2592555C Oligonucleotidic sequences for the amplification of hiv-2 and siv-type retrovirus genome, and their applications for the in vitro diagnosis of infections due to these virus
01/05/2010CA2456183C Il-6/ds-sil-6r fusion protein
01/05/2010CA2381995C Method for the production of proteinaceous substances
01/05/2010CA2369884C Transiently immortalized cells for use in gene therapy
01/05/2010CA2358948C Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
01/05/2010CA2358923C Water-soluble rhodamine dyes and conjugates thereof
01/05/2010CA2349475C Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells
01/05/2010CA2346998C Baculovirus expression system
01/05/2010CA2325664C Food-grade cloning vector and their use in lactic acid bacteria
01/05/2010CA2300480C Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
01/05/2010CA2290717C Nucleic acid binding proteins
01/05/2010CA2281877C Psca: prostate stem cell antigen
01/05/2010CA2260759C Recombinant swinepox virus
01/05/2010CA2252612C Improved transformation method for plants
01/05/2010CA2234119C Improved barstar gene
01/05/2010CA2182810C Bacteriocin from micrococcus varians
01/05/2010CA2164835C Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
01/05/2010CA2143296C New bacillus thuringiensis strains and their insecticidal proteins
01/05/2010CA2062763C Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same
12/2009
12/31/2009US20090328255 Nitrogen limitation adaptability gene and protein and modulation thereof
12/31/2009US20090328254 Novel vip3 toxins and methods of use
12/31/2009US20090328253 DNA Constructs and Methods to Enhance the Production of Commercially Viable Transgenic Plants
12/31/2009US20090328252 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use
12/31/2009US20090328251 Galactosyltransferase
12/31/2009US20090328250 Expression of tgf-beta in plastids
12/31/2009US20090328249 Transplastomic Plants Expressing Lumen-Targeted Protein
12/31/2009US20090328248 Constitutive plant promoters
12/31/2009US20090328247 Isolated DNA sequence capable of serving as regulatory element in a chimeric gene which can be used for the transformation of plants
12/31/2009US20090328246 USE OF THE ocp3 MUTATION TO REGULATE DROUGHT RESISTANCE IN PLANTS
12/31/2009US20090328245 Plants and seeds of corn variety cv427441
12/31/2009US20090328244 Methods and reagents for molecular cloning
12/31/2009US20090328243 Secreted proteins as markers for cell differentiation
12/31/2009US20090328241 Mitochondrial-nuclear exchanged cells, tissues, organs and animals
12/31/2009US20090327170 Methods of Clustering Gene and Protein Sequences
12/31/2009US20090326434 Anti-Microbial Photodynamic Therapy
12/31/2009US20090326206 Single-chain Multiple Antigen-binding Molecule, Its Preparation and Use
12/31/2009US20090326204 Interferon-like protein zcyto21
12/31/2009US20090326200 Altered ospa of borrelia burgdorferi
12/31/2009US20090326054 Compositions and methods for inhibiting translation of a mect1-maml2 chimeric gene
12/31/2009US20090326052 Promoters exhibiting endothelial cell specificity and methods of using same
12/31/2009US20090326051 Modulation of gene expression through endogenous small RNA targeting of gene promoters
12/31/2009US20090326047 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
12/31/2009US20090326046 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/31/2009US20090326045 Compositions and methods for topical delivery of oligonucleotides
12/31/2009US20090326044 RNAi-Mediated Inhibition of Ocular Targets
12/31/2009US20090326043 Method and Compound for Antiviral (HIV) Therapy
12/31/2009US20090326042 Compounds and methods for modulating expression of crp
12/31/2009US20090326041 Compounds and methods for modulating expression of sglt2
12/31/2009US20090326040 Antisense modulation of apolipoprotein b expression
12/31/2009US20090325887 Peptides and regulation of calcium channels
12/31/2009US20090325883 Peptides Which Interact with Anti-Apoptotic Members of the BCL-2 Protein Family, and Uses
12/31/2009US20090325880 Tnf receptor-like molecules and uses thereof
12/31/2009US20090325873 Human glp-1 mimetibodies, compositions, methods and uses
12/31/2009US20090325870 Foamy viral envelope genes
12/31/2009US20090325866 Non-activated wnt inhibition polypeptides and method for preparing the same
12/31/2009US20090325864 Novel protein and process for preparing the same
12/31/2009US20090325818 siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4)
12/31/2009US20090325815 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
12/31/2009US20090325804 Novel glyphosate-n-acetyltransferase (gat) genes
12/31/2009US20090325301 Modulation of the binding properties of nucleic acid binding partners
12/31/2009US20090325298 Pro-Apoptotic Bacteria and Compositions for Delivery and Expression of Antigens
12/31/2009US20090325297 Method for inhibiting expression of a protein in a hepatocyte
12/31/2009US20090325291 METHOD OF PREPARING siRNAs FOR SELECTIVE INHIBITION OF TARGET mRNA ISOTYPES
12/31/2009US20090325290 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
12/31/2009US20090325286 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/31/2009US20090325285 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/31/2009US20090325284 Virus purification
12/31/2009US20090325267 Modified xylanases exhibiting increased thermophilicity and alkalophilicity
12/31/2009US20090325265 High eicosapentaenoic acid producing strains of yarrowia lipolytica
12/31/2009US20090325262 Immobilization of biological molecules onto surfaces coated with monolayers
12/31/2009US20090325248 Microbiological Production of 3-Hydroxypropionic Acid
12/31/2009US20090325244 Method of increasing gene expression using modified codon usage
12/31/2009US20090325241 Sugar transport sequences, yeast strains having improved sugar uptake, and methods of use
12/31/2009US20090325236 Optical sorting method
12/31/2009US20090325230 Protein expression systems
12/31/2009US20090325228 Fungal cell wall synthesis gene
12/31/2009US20090325226 Methods and Compositions for Producing Active Vitamin K-Dependent Proteins
12/31/2009US20090325207 Novel phosphodiesterase and gene thereof
12/31/2009US20090325204 Compounds and methods for diagnosis and treatment of chagas disease
12/31/2009US20090325200 Polypyrimidine-tract binding protein (ptb) as a biomarker and target for the diagnosis and treatment of cancer
12/31/2009US20090325182 Methods for detecting a cyclophilin b snp associated with herda
12/31/2009US20090325181 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/31/2009US20090325180 Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
12/31/2009US20090325168 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
12/31/2009US20090325165 Recombinase polymerase amplification
12/31/2009US20090325162 Fatty acid synthetase, polynucleotide encoding the same, and uses thereof
12/31/2009US20090325155 Aureobasin a synthetase
12/31/2009US20090325150 Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk
12/31/2009US20090325146 Method of determining susceptibility of a tumor cell to a chemotherapeutic agent: novel use of herpes
12/31/2009US20090325145 Methodology for analysis of sequence variations within the hcv ns5b genomic region
12/31/2009US20090324797 Modulating plant oil levels
1 ... 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 ... 4023